Advertisement News Archives - Page 911 of 5231 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

August 4, 2026

FDA grants breakthrough therapy designation to Lilly’s olomorasib

The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Eli Lilly and Company’s (Lilly) olomorasib as a potential treatment for adults with advanced pancreatic cancer who have already received at least one prior systemic therapy.

FDA grants breakthrough therapy designation to Lilly’s olomorasib